New Allergan character bows for Zenpep by Beth Snyder Bulik Monday, April 2, 2018 Eddie the Enzyme is ready to break down food and take on the competition in pancreatic enzyme products.
Brineura, Imfinzi square off in #FierceMadness final by Beth Snyder Bulik Monday, April 2, 2018 The final showdown is set: BioMarin’s Brineura will face off against AstraZeneca’s Imfinzi in the drug name championship for 2018.
Daiichi Sankyo campaign spots iron deficiency by Beth Snyder Bulik Sunday, April 1, 2018 A new disease awareness campaign from Daiichi Sankyo highlights iron deficits common in patients with Crohn’s disease and ulcerative colitis.
The #FierceMadness Final Four is set by Beth Snyder Bulik Wednesday, March 28, 2018 We're down to four, folks. The #FierceMadness Final Four field is set after an Elite Eight that featured both blowouts and close calls.
Hikma rebrands to create modern visual identity by Beth Snyder Bulik Wednesday, March 28, 2018 Hikma Pharmaceuticals is changing up more than just its CEO. It's rebranded, with a modern logo and visual identity.
Trulance, Yescarta head into the #FierceMadness Elite Eight by Beth Snyder Bulik Monday, March 26, 2018 Never underestimate the power of positivity, which triumphed in the latest round of voting in FiercePharma’s drug-naming shootout.
Pharma's social media strategies are growing up: report by Beth Snyder Bulik Monday, March 26, 2018 Pharma companies are maturing on social media, if Ogilvy Healthworld’s latest Social Check-up report is any indication.
Alnylam taps extended family for rare-disease campaign by Beth Snyder Bulik Monday, March 26, 2018 Alnylam highlights the power of family in hereditary diseases, putting the spotlight on one extended family in its new disease awareness campaign.
Amgen awards media to Omnicom by Beth Snyder Bulik Monday, March 26, 2018 Media agency Hearts & Science picked up Amgen’s estimated $350 million media account. The review included the retention of Amgen’s HCP business.
Pfizer's Ibrance joins February's TV ad-spending leaders by Beth Snyder Bulik Friday, March 23, 2018 Debut ads helped drive list-toppers for pharma TV spend in February, with Ibrance, Otezla, Rexulti, Entresto and Eliquis entering the top 10.
